Sugganth Daniel

855 total citations
26 papers, 313 citations indexed

About

Sugganth Daniel is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Sugganth Daniel has authored 26 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Sugganth Daniel's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Sugganth Daniel is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Sugganth Daniel collaborates with scholars based in United States, France and Italy. Sugganth Daniel's co-authors include Laurie M. Gay, Jo‐Anne Vergilio, Jeffrey S. Ross, Julia A. Elvin, Shakti Ramkissoon, Eric A. Severson, Vincent A. Miller, Siraj M. Ali, Alexa B. Schrock and James Suh and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

Sugganth Daniel

26 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sugganth Daniel United States 7 196 96 70 67 62 26 313
Gary Zeger United States 12 156 0.8× 151 1.6× 48 0.7× 45 0.7× 61 1.0× 19 315
Débora S. Bruno United States 12 215 1.1× 128 1.3× 82 1.2× 23 0.3× 51 0.8× 45 352
Oscar Mang China 7 233 1.2× 49 0.5× 80 1.1× 53 0.8× 45 0.7× 8 515
Fabrice Jardin France 9 81 0.4× 59 0.6× 58 0.8× 110 1.6× 50 0.8× 22 277
Vittorio Fregoni Italy 11 157 0.8× 52 0.5× 36 0.5× 35 0.5× 51 0.8× 23 383
Çağlayan Geredeli Türkiye 10 210 1.1× 108 1.1× 73 1.0× 37 0.6× 52 0.8× 49 304
K Govind Babu India 9 124 0.6× 42 0.4× 63 0.9× 27 0.4× 48 0.8× 33 250
Lydia Dreosti South Africa 10 300 1.5× 179 1.9× 75 1.1× 30 0.4× 157 2.5× 20 472
M. Martín Jiménez Spain 10 200 1.0× 133 1.4× 79 1.1× 12 0.2× 27 0.4× 56 323
Varol Çelik Türkiye 12 91 0.5× 70 0.7× 138 2.0× 191 2.9× 48 0.8× 34 431

Countries citing papers authored by Sugganth Daniel

Since Specialization
Citations

This map shows the geographic impact of Sugganth Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sugganth Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sugganth Daniel more than expected).

Fields of papers citing papers by Sugganth Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sugganth Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sugganth Daniel. The network helps show where Sugganth Daniel may publish in the future.

Co-authorship network of co-authors of Sugganth Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Sugganth Daniel. A scholar is included among the top collaborators of Sugganth Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sugganth Daniel. Sugganth Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Jeffrey S., Marwan Fakih, Siraj M. Ali, et al.. (2018). Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. 124(7). 1358–1373. 149 indexed citations
2.
Necchi, Andrea, Gennady Bratslavsky, Robert J. Corona, et al.. (2018). Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. European Urology Focus. 6(1). 122–130. 34 indexed citations
3.
Necchi, Andrea, Gennady Bratslavsky, Robert J. Corona, et al.. (2018). Comprehensive genomic characterization of chemotherapy-resistant testicular germ cell tumors (TGCT).. Journal of Clinical Oncology. 36(15_suppl). 4555–4555. 2 indexed citations
4.
Girard, Nicolas, Julia A. Elvin, James Suh, et al.. (2018). Primary pulmonary sarcomas (PSRC): A comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 36(15_suppl). 11553–11553. 1 indexed citations
5.
Ali, Siraj M., Laurie M. Gay, Julia A. Elvin, et al.. (2018). MSI-high and MSI-stable colorectal carcinomas (CRC): A comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 36(15_suppl). 3574–3574. 3 indexed citations
6.
7.
Severson, Eric A., Jo‐Anne Vergilio, Laurie M. Gay, et al.. (2018). Genomic Landscape of Adult and Pediatric BCR-ABL1-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing. The Oncologist. 24(3). 372–374. 5 indexed citations
8.
Ross, Jeffrey S., Laurie M. Gay, Ethan Sokol, et al.. (2018). PBRM1 genomic alterations in mesothelioma: Potential predictor of immunotherapy efficacy.. Journal of Clinical Oncology. 36(15_suppl). 8562–8562. 2 indexed citations
9.
Severson, Eric A., Shakti Ramkissoon, Sugganth Daniel, et al.. (2017). Association of tumor mutational burden in cutaneous squamous cell carcinoma with genomic alterations in Notch family receptors.. Journal of Clinical Oncology. 35(15_suppl). e13031–e13031. 1 indexed citations
10.
Vergilio, Jo‐Anne, Laurie M. Gay, Sugganth Daniel, et al.. (2017). PATH-20. COMPREHENSIVE GENOMIC PROFILING COMPARING PRIMARY CNS LYMPHOMA TO SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA REVEALS BIOMARKERS INDICATING POTENTIAL BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS. Neuro-Oncology. 19(suppl_6). vi175–vi175. 2 indexed citations
11.
Johnson, Douglas B., J. Andrew Carlson, Julia A. Elvin, et al.. (2017). Landscape of genomic alterations (GA) and tumor mutational burden (TMB) in different metastatic melanoma (MM) subtypes.. Journal of Clinical Oncology. 35(15_suppl). 9536–9536. 18 indexed citations
12.
Elvin, Julia A., Yuting He, James Sun, et al.. (2017). Comprehensive genomic profiling (CGP) with loss of heterozygosity (LOH) to identify therapeutically relevant subsets of ovarian cancer (OC).. Journal of Clinical Oncology. 35(15_suppl). 5512–5512. 10 indexed citations
13.
Ross, Jeffrey S., Siraj M. Ali, Julia A. Elvin, et al.. (2017). Occurrence of ALK fusions in cancers other than non-small cell lung cancer in a wide variety of tumor types and response to anti-ALK targeted therapy.. Journal of Clinical Oncology. 35(15_suppl). 11595–11595. 1 indexed citations
14.
Daniel, Sugganth, Erica Gornstein, Garrett M. Frampton, et al.. (2017). BRCA1/2 reversion mutations in prostate cancer identified from clinical tissue and liquid biopsy samples.. Journal of Clinical Oncology. 35(15_suppl). 5024–5024. 1 indexed citations
15.
Daniel, Sugganth, Laurie M. Gay, Jo‐Anne Vergilio, & Jeffrey S. Ross. (2017). A clinical and genomic profile of inflammatory myofibroblastic tumors.. Journal of Clinical Oncology. 35(15_suppl). 1538–1538. 6 indexed citations
16.
Mayor, Paul, Laurie M. Gay, Erica Gornstein, et al.. (2017). BRCA1/2 reversion mutations revealed in breast and gynecologic cancers sequenced during routine clinical care using tissue or liquid biopsy.. Journal of Clinical Oncology. 35(15_suppl). 5551–5551. 2 indexed citations
17.
Albanell, Joan, Julia A. Elvin, Siraj M. Ali, et al.. (2017). BRAF: An emerging target for triple-negative breast cancer.. Journal of Clinical Oncology. 35(15_suppl). 1099–1099. 8 indexed citations
18.
Ross, Jeffrey S., Siraj M. Ali, Julia A. Elvin, et al.. (2017). Targeted therapy for HER2 driven colorectal cancer.. Journal of Clinical Oncology. 35(15_suppl). 3583–3583. 6 indexed citations
19.
Gay, Laurie M., David Fabrizio, Garrett M. Frampton, et al.. (2017). Mutational burden of tumors with primary site unknown.. Journal of Clinical Oncology. 35(15_suppl). 3039–3039. 3 indexed citations
20.
Friedman, Mark T., et al.. (2012). Informed Consent for Blood Transfusion. American Journal of Clinical Pathology. 138(4). 559–565. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Zeger Breakdown of academic impact, for papers by Débora S. Bruno Breakdown of academic impact, for papers by Oscar Mang Breakdown of academic impact, for papers by Fabrice Jardin Breakdown of academic impact, for papers by Vittorio Fregoni Breakdown of academic impact, for papers by Çağlayan Geredeli Breakdown of academic impact, for papers by K Govind Babu Breakdown of academic impact, for papers by Lydia Dreosti Breakdown of academic impact, for papers by M. Martín Jiménez Breakdown of academic impact, for papers by Varol Çelik
Rankless by CCL
2026